bioRxiv Science⌕ Search

Biology subjects

Dawson, R.

Publications and source records attributed to Dawson, R..

5 recordsLinked to original sources

ZHP-2/HEI10 generates CO precursors and triggers procrossover factor coarsening and CO formation through Polo kinase recruitment

During meiosis, programmed DNA double-strand breaks (DSBs) are repaired with the homolog to form crossovers (COs) essential for chromosome segregation, or noncrossovers (nCOs) to restore genomic integrity. Only a few recombination intermediates will become COs and these sites are progressively enriched in proCO factors at the expense of nCO sites, referred to as coarsening. Here, we show that in C. elegans this process is engineered by ZHP-2/HEI10, a conserved E3 ligase that has functions at early and late stages of CO formation. Early on, ZHP-2-mediated loss of RMH-1/RMI1 and HIM-6/BLM from strand exchange intermediates is required for joint molecule formation and nCO repair. In zhp-2 mutants, proCO factors accumulate at HR sites, leading to defects in CO formation and CO spacing. We find that Polo kinase recruitment to a ZHP-2 at CO precursors signals an end to further DSB formation, and triggers proCO factor coarsening and CO formation. We propose that ZHP-2 disassembles proCO factors from recombination intermediates until it is inactivated at CO precursors through Polo kinase recruitment, leading to stabilization of proCO factors, and resolution of joint molecules as crossovers. Our study reveals that ZHP-2/HEI10 is the central component of a Polo kinase-driven switch that initiates proCO factor coarsening and execution of crossing over.

cell biology↗

Tackling Bias in Cortical Thickness Estimation in UK Biobank Using Harmonisation Approaches

Big neuroimaging data enable researchers to study subtle structural and functional brain changes and relationships between brain characteristics and genetics, lifestyle, and disease factors. However, substantial effort is needed to minimise technical, non-biological differences between data batches to avoid incorrect inferences. In this study, we address a previously identified bias in UK Biobank FreeSurfer IDPs derived from only the T1 image compared to those using both T1 and T2-FLAIR by treating the bias as a batch effect and using harmonisation approaches. We investigate and characterise this bias through direct within-participant comparison at the image and IDP level, comparing the results with those seen in the wider UKB sample. We then assess different methods of addressing the effect of missing T2-FLAIR, starting from simple linear regression before moving to ComBat, a widely used harmonisation method, testing different approaches for applying ComBat and showing its similarity to simple linear regression. Finally, we examine how ComBat estimates vary with batch and sample size. Our results show clear benefits in using both T1 and T2-FLAIR data in FreeSurfer, as opposed to just the T1, which is more common, with the pial surface fitting being less likely to fail and showing greater biologically plausible inter-subject variability. This is particularly important for cortical thickness IDPs, where T2-FLAIR omission leads to reduced true variability and systematic underestimation, as shown through within-participant repeat testing. We demonstrate that ComBat can address this bias, with its standard use (i.e., applied separately on different IDP categories) showing the best improvement in cortical thickness measures where the bias is strongest, and we find that it is important not to pool ComBat priors across different classes of IDPs. Our proposed version of ComBat with a reference batch (i.e., estimating mean and variance only from data with T2-FLAIR available) performed best in recovering both mean and variance differences between batches across different IDP classes and offers a promising approach for cases where a reference batch is clearly identifiable. While ComBat reliably corrects mean (additive) batch effects with relatively small sample sizes ({approx}30 subjects per batch), we show that its variance (multiplicative) correction is substantially less stable, requiring much larger sample sizes and becoming unreliable when batches are small or imbalanced, or when there is a large variance difference between them.

neuroscience↗

High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: evidence for heteroresistance

BackgroundAntibiotic treatments are often associated with a late slowdown in bacterial killing. This separates the killing of bacteria into at least two distinct phases: a quick phase followed by a slower phase, the latter of which is linked to treatment success. Current mechanistic explanations for the in vitro slowdown are either antibiotic persistence or heteroresistance. Persistence is defined as the switching back and forth between susceptible and non-susceptible states, while heteroresistance is defined as the coexistence of bacteria with heterogeneous susceptibilities. Both are also thought to cause a slowdown in the decline of bacterial populations in patients and therefore complicate and prolong antibiotic treatments. Reduced bacterial death rates over time are also observed within tuberculosis patients, yet the mechanistic reasons for this are unknown and therefore the strategies to mitigate them are also unknown. Methods and FindingsWe analyse a dose ranging trial for rifampicin in tuberculosis patients and show that there is a slowdown in the decline of bacteria. We show that the late phase of bacterial killing depends more on the peak drug concentrations than the total drug exposure. We compare these to pharmacokinetic-pharmacodynamic models of rifampicin heteroresistance and persistence. We find that the observation on the slow phases dependence on pharmacokinetic measures, specifically peak concentrations are only compatible with models of heteroresistance and incompatible with models of persistence. The quantitative agreement between heteroresistance models and observations is very good [Formula]. To corroborate the importance of the slowdown, we validate our results by estimating the time to sputum culture conversion and compare the results to a different dose ranging trial. ConclusionsOur findings indicate that higher doses, specifically higher peak concentrations may be used to optimize rifampicin treatments by accelerating bacterial killing in the slow phase. It adds to the growing body of literature supporting higher rifampicin doses for shortening tuberculosis treatments.

microbiology↗

The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development

Enhancers are vitally important during embryonic development to control the spatial and temporal expression of genes. Recently, large scale genome projects have identified a vast number of putative developmental regulatory elements. However, the proportion of these that have been functionally assessed is relatively low. While enhancers have traditionally been studied using reporter assays, this approach does not characterise their contribution to endogenous gene expression. We have studied the murine Nestin (Nes) intron 2 enhancer, which is widely used to direct exogenous gene expression within neural progenitor cells in cultured cells and in vivo. We generated CRISPR deletions of the enhancer region in mice and assessed their impact on Nes expression during embryonic development. Loss of the Nes neural enhancer significantly reduced Nes expression in the developing CNS by as much as 82%. By assessing NES protein localization, we also show that this enhancer region contains repressor element(s) that inhibit Nes expression within the vasculature. Previous reports have stated that Nes is an essential gene, and its loss causes embryonic lethality. We also generated 2 independent Nes null lines and show that both develop without any obvious phenotypic effects. Finally, through crossing of null and enhancer deletion mice we provide evidence of trans-chromosomal interaction of the Nes enhancer and promoter.

developmental biology↗

Re-Evaluating One-step Generation of Mice Carrying Conditional Alleles by CRISPR-Cas9-Mediated Genome Editing Technology

CRISPR-Cas9 gene editing technology has considerably facilitated the generation of mouse knockout alleles, relieving many of the cumbersome and time-consuming steps of traditional mouse embryonic stem cell technology. However, the generation of conditional knockout alleles remains an important challenge. An earlier study reported up to 16% efficiency in generating conditional knockout alleles in mice using 2 single guide RNAs (sgRNA) and 2 single-stranded oligonucleotides (ssODN) (2sgRNA-2ssODN). We re-evaluated this method from a large data set generated from a consortium consisting of 17 transgenic core facilities or laboratories or programs across the world. The dataset constituted 17,887 microinjected or electroporated zygotes and 1,718 live born mice, of which only 15 (0.87%) mice harbored 2 correct LoxP insertions in cis configuration indicating a very low efficiency of the method. To determine the factors required to successfully generate conditional alleles using the 2sgRNA-2ssODN approach, we performed a generalized linear regression model. We show that factors such as the concentration of the sgRNA, Cas9 protein or the distance between the placement of LoxP insertions were not predictive for the success of this technique. The major predictor affecting the methods success was the probability of simultaneously inserting intact proximal and distal LoxP sequences, without the loss of the DNA segment between the two sgRNA cleavage sites. Our analysis of a large data set indicates that the 2sgRNA-2ssODN method generates a large number of undesired alleles (>99%), and a very small number of desired alleles (<1%) requiring, on average 1,192 zygotes.

genetics↗